| Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study. | |
| | |
MedLine Citation:
|
PMID: 22388767 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The prevalence of cardiovascular diseases is rising. Therefore, adequate risk prediction and identification of its determinants is increasingly important. The Rotterdam Study is a prospective population-based cohort study ongoing since 1990 in the city of Rotterdam, The Netherlands. One of the main targets of the Rotterdam Study is to identify the determinants and prognosis of cardiovascular diseases. Case finding in epidemiological studies is strongly depending on various sources of follow-up and clear outcome definitions. The sources used for collection of data in the Rotterdam Study are diverse and the definitions of outcomes in the Rotterdam Study have changed due to the introduction of novel diagnostics and therapeutic interventions. This article gives the methods for data collection and the up-to-date definitions of the cardiac outcomes based on international guidelines, including the recently adopted cardiovascular disease mortality definitions. In all, detailed description of cardiac outcome definitions enhances the possibility to make comparisons with other studies in the field of cardiovascular research and may increase the strength of collaborations. |
| | |
Authors:
|
Maarten J G Leening; Maryam Kavousi; Jan Heeringa; Frank J A van Rooij; Jolande Verkroost-van Heemst; Jaap W Deckers; Francesco U S Mattace-Raso; Gijsbertus Ziere; Albert Hofman; Bruno H Ch Stricker; Jacqueline C M Witteman |
Related Documents
:
|
22166407 - Pulsatile or continuous dopaminomimetic strategies in parkinson's disease. 22016407 - Principle: a tool for associating genes with diseases via network propagation. 21975017 - Xvi european charcot foundation lecture: nutrition and environment: can ms be prevented? 21624507 - A clear look at the neuroimmunology of multiple sclerosis and beyond. 16180157 - Alzheimer's disease and stroke. 21595567 - Connective tissue growth factor (ctgf/ccn2) elisa: a novel tool for monitoring fibrosis. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-3-3 |
Journal Detail:
|
Title: European journal of epidemiology Volume: - ISSN: 1573-7284 ISO Abbreviation: - Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-3-5 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8508062 Medline TA: Eur J Epidemiol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Epidemiology, Erasmus Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A genetic instrument for Mendelian randomization of fibrinogen.
Next Document: Repeated measures of body mass index and risk of health related outcomes.